Results 121 to 130 of about 230,623 (311)

Supplementary Figure 4 from Aberrant Activation of the Androgen Receptor by NF-κB2/p52 in Prostate Cancer Cells

open access: gold, 2023
Nagalakshmi Nadiminty   +8 more
openalex   +1 more source

Role of the androgen receptor in melanoma aggressiveness

open access: yesCell Death and Disease
Malignant melanoma represents the fifth most common cancer in the world and its incidence is rising. Novel therapies targeting receptor tyrosine kinases, kinases and immune checkpoints have been employed with a significant improvement of the overall ...
Marzia Di Donato   +11 more
doaj   +1 more source

In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer [version 4; peer review: 2 approved]

open access: yesF1000Research
Background: Prostate cancer is a disease that occurs in men aged more than 50 years. In Iraq, 8.89 men per 100,000 population suffer from prostate cancer, with the incidence being 14,016 cases and mortality being 6,367 cases.
Hany Akeel Al-Hussaniy   +2 more
doaj   +1 more source

Structure of the homodimeric androgen receptor ligand-binding domain

open access: yesNature Communications, 2017
The androgen receptor is crucial for the development and physiology of reproductive organs. Here the authors present the structure of the androgen receptor ligand-binding domain bound to dihydrotestosterone, identifying a homodimerization interface that ...
Marta Nadal   +13 more
doaj   +1 more source

Evidence for the Presence of Androgen Receptors in Purified Rat Leydig Cells [PDF]

open access: bronze, 1983
S. Gulizia   +3 more
openalex   +1 more source

Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Treatment with enzalutamide in prostate cancer is challenging due to its high potential for drug–drug interactions, particularly in the typically older population of patients with frequent comorbidities treated with multiple drugs, such as anticoagulants.
Catharina J. P. Op 't Hoog   +8 more
wiley   +1 more source

Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Mitotane is an adrenolytic drug with cytotoxic effects, registered for the treatment of advanced adrenocortical carcinoma (ACC), a rare but aggressive tumour type with a poor prognosis despite treatment. Recently, the oral multi‐kinase inhibitor cabozantinib has shown promising results as a potential second‐line treatment option.
Annemieke M. Peters van Ton   +4 more
wiley   +1 more source

Supplementary Table 1 from Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer

open access: gold, 2023
Ricardo M. Attar   +17 more
openalex   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

open access: yesBMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan   +8 more
wiley   +1 more source

Reseptor Androgen dan Organ Reproduksi Pria

open access: yesJKS (Jurnal Kedokteran Syiah Kuala), 2006
Abstrak.   Hormon  androgen  berperan  penting    dalam   perkembangan   scksual    individu    jaruan.   Mormon   androgen yang  penting  adalah   hormon  testosteron   dan  hormon  dyindrotestosteron.
Zulfitri Zulfitri
doaj  

Home - About - Disclaimer - Privacy